What RadNet does

RadNet, Inc. (NASDAQ: RDNT) is the largest provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States, operating 440 centers across 11 states (AZ, CA, DE, FL, ID, IN, MD, NJ, NY, TX, VA) as of May 2026 and completing more than 11.5 million imaging procedures annually. The company generates fee-for-service revenue from MRI, CT, PET/CT, mammography, X-ray, and ultrasound procedures reimbursed by Medicare, Medicaid, commercial payors, and patients, with additional managed-service revenue from hospital and health-system joint ventures including Trinity Health Saint Alphonsus (Idaho).

RadNet's technology stack is anchored by its wholly owned DeepHealth subsidiary, an AI-powered radiology platform covering all major imaging modalities with 26 FDA-cleared devices and CE marks following acquisitions of Gleamer SAS (€230M), iCAD ($103M), Cimar UK, See-Mode Technologies, Aidence, and Quantib. Proprietary products include the DeepHealth Breast Suite (21% increase in breast cancer detection in a study of 579,000+ women), Reporting Pro (generative AI radiology reporting with speech recognition), TechLive (remote scanner operations with 42% reduction in MR room closure hours), and the eRAD cloud-based radiology information system. DeepHealth commercializes AI software externally through 2,700+ customer contracts across 50+ countries and operates as a SaaS business targeting $140M+ ARR by year-end 2026.

The company combines an enterprise field sales motion for hospital JV and AI software sales with direct-to-consumer marketing for patient acquisition across its owned center network. Founded in 1980 and headquartered in Los Angeles, RadNet has grown from approximately 6,000 employees and 150 centers to roughly 11,000 employees and 440+ centers, supplemented by a digital health division in Somerville, Massachusetts. The company is led by co-founder and CEO Dr. Howard Berger (since 1980) and CFO Mark Stolper (since 2004), with Kees Wesdorp overseeing the DeepHealth digital health division.

Name

RadNet

Legal name

RadNet, Inc.

Website

https://radnet.com

Company type

Public

Founded year

1980

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

RadNet is the largest US operator of freestanding outpatient diagnostic imaging centers, running 440 facilities across 11 states that complete 11.5M+ procedures annually, while monetizing AI radiology software through its DeepHealth subsidiary across 50+ countries.

Ownership category

akta.pro rank

Product category

Outpatient Diagnostic Imaging Services

NAICS

Diagnostic Imaging Centers (621512), Ambulatory Health Care Services (621)

SIC

Services-Health Services (8000)

akta.pro primary industry

Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound) (HLAFAKAA)

akta.pro secondary industries

Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD), Vendor Neutral Archive (VNA) & Enterprise Imaging Repositories (HLACALAC), Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web) (HLACALAI), Quality, Peer Review & Compliance Tools (MQSA/ACR/QA) (HLACALAL), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB), Women’s Imaging & Breast Health Centers (HLAFAJAJ)

Keywords

• Outpatient diagnostic imaging
• Radiology AI solutions
• Medical imaging services
• Mammography screening centers
• Imaging workflow software

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain, Others

Revenue model

1. Imaging Center Services: Fee-for-service outpatient diagnostic imaging services including MRI, CT, PET/CT, mammography, X-ray, and ultrasound across over 440 centers; revenue from payors (Medicare, Medicaid, commercial insurers) and patients
2. Digital Health / AI Solutions: SaaS-based AI-powered radiology solutions through DeepHealth subsidiary; annual recurring revenue model targeting $140 million+ ARR by end of 2026; includes FDA-cleared clinical AI tools deployed across imaging modalities
3. Hospital Joint Ventures: Strategic partnerships with hospitals and health systems where RadNet manages imaging operations; revenue share or management fees; helps hospitals shift imaging to outpatient settings

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

RadNet operates the largest US network of freestanding, fixed-site outpatient diagnostic imaging centers, providing MRI, CT, PET/CT, mammography, X-ray, and ultrasound services across 440 centers in 11 states. Through its DeepHealth subsidiary, RadNet develops and sells AI-powered radiology software solutions, cloud-based imaging management (eRAD), and clinical AI tools for breast, lung, prostate, and brain imaging, serving external customers in over 50 countries alongside internal deployment.

Product overview

RadNet operates as both a healthcare services provider and a technology company, combining a network of 440 outpatient diagnostic imaging centers across 11 U.S. states with AI-powered digital health solutions through its DeepHealth subsidiary. The core offering consists of outpatient imaging services (MRI, CT, PET/CT, mammography, X-ray, ultrasound) supported by the eRAD radiology information and image management system. The DeepHealth AI platform, which RadNet describes as the world's largest provider of radiology clinical AI solutions, integrates specialized modules including the Breast Suite for mammography AI (with BAC Assessment and Mammo Dx FDA clearances), Reporting Pro for AI-powered radiology reporting, and TechLive for remote imaging operations. The company completed over 11.5 million outpatient imaging procedures annually as of December 2025.

Differentiator

Problem solved

Functional benefit

Brands

• DeepHealth: Wholly-owned subsidiary providing AI-powered radiology solutions including breast, lung, prostate, and brain imaging AI tools; FDA-cleared clinical AI products; radiology workflow automation; operates under DeepHealth OS platform
• eRAD
• DeepHealth Breast Suite
• Reporting Pro
• TechLive
• MammogramNow

Products and services

• Outpatient Imaging Centers Largest network of freestanding, fixed-site outpatient diagnostic imaging centers in the US offering MRI, CT, PET/CT, mammography, X-ray, and ultrasound services to patients across 11 states (AZ, CA, DE, FL, ID, IN, MD, NJ, NY, TX, VA).
• DeepHealth AI Platform Wholly-owned subsidiary providing AI-powered radiology solutions, including clinical AI tools for breast, lung, prostate, and brain imaging, operating on the DeepHealth OS platform with cloud-based clinical imaging management. Deployed across RadNet's network and sold to external customers in 50+ countries.
• eRAD Integrated web-based, cloud Radiology Information System (RIS) and image management solutions for medical imaging workflow, sold to external customers and used internally across RadNet's center network.
• DeepHealth Breast Suite AI-powered mammography workflow suite integrating with GE HealthCare's Senographe Pristina system to improve breast cancer detection. Clinical studies show 21% increase in breast cancer detection rates across 579,000+ women.
• BAC Assessment FDA 510(k) cleared AI tool that detects cardiovascular disease risk indicators through breast arterial calcification assessment during routine mammograms, demonstrating over 90% sensitivity and 88% specificity across dense and non-dense breast tissue.
• Mammo Dx FDA 510(k) cleared AI tool that compares prior and current mammography exams to improve cancer detection accuracy; deployed across RadNet's imaging center network and commercially available in the United States.
• Reporting Pro AI-powered radiology reporting solution that integrates speech recognition, clinical AI findings, measurements, and generative AI-generated impressions into a unified workflow, addressing radiologist shortages projected at 15% in the US by 2029 and 40% in parts of Europe by 2030.
• TechLive FDA-cleared and CE-marked remote imaging solution enabling certified technologists to remotely operate and manage MR, CT, PET/CT, and ultrasound scanners through a consolidated interface. Demonstrated 42% reduction in MR room closure hours and 27% increase in advanced breast MRI procedures.
• CIMAR UK Cloud Imaging Platform Cloud-native healthcare image management platform integrated into DeepHealth, serving 50% of NHS trusts and 80% of UK private hospital groups with imaging data connectivity and lung cancer screening program support.
• Hospital and Health System Joint Ventures Strategic joint ventures with hospitals and health systems where RadNet manages imaging operations and deploys DeepHealth AI technology, helping hospitals shift imaging to outpatient settings while earning management fees or revenue share.

Quantifiable outcome

• 21% increase in breast cancer detection rates using AI-powered mammography (study of 579,000+ women)
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and major.

• Trinity Health Saint Alphonsus Health SystemcoreStrategic or Co-development Partner · 30 April 2026Joint venture through acquisition of majority equity position in Intermountain Medical Imaging LLC, jointly operating five imaging facilities in Boise, Idaho area. RadNet assumes management of all five locations and implements DeepHealth AI technology. Projected to generate approximately $30 million in annual revenue. Deal marks RadNet's 11th state and second new state in 2026.
• GE HealthCarecoreStrategic or Co-development Partner · 16 April 2026Expanded collaboration to commercialize AI-powered mammography tools globally. DeepHealth's Breast Suite AI integrated with GE HealthCare's Senographe Pristina mammography system. New applications include ProFound Pro and Safeguard Review. Clinical studies show 21% increase in breast cancer detection rates using AI-driven workflow. Partnership extends internationally with Pristina Via system.
• Gleamer SAScoreTechnology or Integration · 2 March 2026Acquired Paris-based radiology AI company for up to €230 million ($267-270M). Makes DeepHealth the world's largest provider of radiology clinical AI solutions worldwide with 2,700+ customer contracts across 50+ countries. Gleamer brings FDA-cleared and CE-marked AI solutions covering musculoskeletal, breast, lung, and neurologic indications. Expected ARR of approximately $30 million in 2026 with 90%+ CAGR from 2022-2025.
• Northwest Radiology NetworkmajorStrategic or Co-development Partner · 3 February 2026Acquisition of outpatient imaging assets marking RadNet's entry into Midwest with six multimodality imaging centers in greater Indianapolis, Indiana area. Expected to add approximately $18 million in annual revenue. Northwest Radiology's 18 radiologists continue providing contracted professional services.
• Cimar UKmajorTechnology or Integration · 11 November 2025Acquisition of Cimar UK to enhance AI-powered imaging and data connectivity capabilities. Cimar's cloud-native infrastructure and existing NHS partnerships integrated into DeepHealth subsidiary. Supports earlier disease detection and expansion of digital health services across UK and Europe, particularly in lung cancer screening programs.
• iCAD Inc.majorTechnology or Integration · 1 July 2025Acquired iCAD Inc. for approximately $103 million to strengthen AI-powered breast cancer detection capabilities. Integration of iCAD's imaging and risk evaluation technologies into DeepHealth portfolio, accelerating AI-powered breast health technologies.
• Heart & Lung Imaging LimitedmajorStrategic or Co-development Partner · 1 November 2022Acquired 75% interest in London-based provider of lung cancer screening services to UK NHS. Part of strategy to implement early detection screening for cancers and chronic diseases. Program could lead to over one million lung scans in England by 2026.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• SimonMed Imaging: One of the largest outpatient diagnostic imaging networks in the US operating hundreds of centers across multiple states with MRI, CT, ultrasound, mammography, and X-ray offerings. Most directly comparable to RadNet's core outpatient imaging center business by modality mix and patient segment.
• Akumin: Multi-modality outpatient diagnostic imaging provider operating a national network of fixed-site imaging centers in the US with a similar MRI/CT/mammography portfolio. Directly competes with RadNet in regional markets and pursues a similar outpatient-shifting strategy versus hospital-based imaging.
• US Radiology Specialists: PE-backed (Welsh Carson) operator of outpatient imaging centers across multiple US states, formed through roll-up acquisitions of regional radiology practices. Closely comparable to RadNet's hub-and-spoke acquisition model and hospital joint venture approach.
• Center for Diagnostic Imaging (CDI): Outpatient imaging network owned by InTandem Capital Partners operating diagnostic imaging centers across the US with MRI, CT, and women's imaging services. Similar fixed-site outpatient model and patient payor mix to RadNet's center operations.

Broad incumbents

• GE HealthCare: Global medical imaging hardware and informatics incumbent with mammography (Senographe Pristina), MRI, CT, and AI-enabled imaging software. Both a strategic partner (DeepHealth Breast Suite integration) and a competitor in the AI radiology space.
• Siemens Healthineers: Global medical imaging OEM with MRI, CT, PET, and AI-Rad Companion radiology AI portfolio. Provides comparable MRI/CT equipment and competes with DeepHealth through native AI bundling and broad enterprise contracts with hospitals.
• Philips Healthcare: Medical imaging, diagnostic informatics, and AI vendor serving radiology departments worldwide. Competes in imaging informatics (PACS/RIS) where eRAD also operates, and bundles AI capabilities alongside Intellispace Portal offerings.
• Hologic: Women's health and mammography hardware/software leader including 3Dimensions mammography systems and Genius AI Detection software. Directly overlaps with RadNet's DeepHealth Breast Suite and MammogramNow offerings in breast cancer screening AI.

Emerging players

• Aidoc: AI radiology vendor with FDA-cleared algorithms for CT triage and detection across multiple modalities, deployed across hundreds of hospital systems. Comparable as a standalone AI clinical solutions provider competing with DeepHealth for radiology AI contracts.
• Qure.ai: Mumbai-based radiology AI company with FDA-cleared and CE-marked solutions for chest CT, head CT, and chest X-ray, sold across 50+ countries. Overlaps with Gleamer's geographic reach and competes for similar AI imaging deployment customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks3 records

Key highlights7 records

Customer concentration

• Xx.com/radnetimaging
• YouTubeyoutube.com/user/RadNetVideos
• Facebookfacebook.com/RadNetImaging
• LinkedInlinkedin.com/company/radnet

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries10 records

Funding overview

Funding rounds5 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A14 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RadNet